
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Jason Luke, MD, assistant professor at the University of Chicago Medicine, discusses what he hopes the future of advanced melanoma treatment will look like.
Jason Luke, MD, assistant professor at the University of Chicago Medicine, discusses what he hopes the future of advanced melanoma treatment will look like.
With new agents and combinations, long-term melanoma survival will continue to improve. Luke hopes that the future landscape for advanced melanoma -- and all cancers -- will become similar to managing a chronic disease. To do this, there must be treatments with high efficacy and low toxicity profiles.






